Optiscan Imaging : Appendix 4D and 31 December 2021 Half-year report

Optiscan Imaging Limited

Appendix 4D

Half-year report

1. Company details

	Name of entity:	Optiscan Imaging Limited
	ABN:	81 077 771 987
only	For the half-year ended 31 December 2021
	Reporting period:
	Previous period:	For the half-year ended 31 December 2020
	2. Results for announcement to the market
					$
	Revenues from ordinary activities	up	4.2%	to	555,789
use
	Loss from ordinary activities after tax attributable to the owners of
	Optiscan Imaging Limited	up	156.3%	to	(1,926,957)
	Lo for the half-year attributable to the owners of Optiscan Imaging
	Limited	up	156.3%	to	(1,926,957)
	Dividends
	There were no dividends paid or declared during the current financial period.
personal
	Comments

The loss for the consolidated entity after providing for income tax amounted to $1,926,957 (31 December 2020: $751,715).

Fin ncial performance

During the 6 month period to 31 December 2021 (H1FY22), the consolidated entity generated ordinary revenue of $555,789 from sales, system rentals and the provision of services, compared to $533,574 in the previous corresponding period.

The consolidated entity also recorded research and development incentive income for H1FY22 $594,669, an increase of $305,029 from the previous corresponding period (2021: $289,640). Income of $279,255 for H1FY22 was recorded from the BioMedTech Horizons program grant, which was an increase of $29,686 from the previous corresponding period (2021: $249,569).

Total expenses for H1FY22, excluding research and development and intellectual property expenses, were $2,016,343, an incr ase of $843,873 from the corresponding period (2020: $1,172,470). Research and development and intellectual property

xp nses were $1,367,056, an increase of $701,217 from the previous corresponding period of $665,839.

Financial position

The net assets decreased by $1,505,171 to $8,711,935 at 31 December 2021 (30 June 2021: $10,217,106) primarily due expenditure on the consolidated entity's operational activities and working capital requirements.

ForThe working capital position of the consolidated entity as at 31 December 2021 resulted in an excess of current assets over current liabilities of $8,531,561 (30 June 2021: $9,995,498).

Net cash used in operating activities was $1,328,241, an increase of $1,152,204 compared to the corresponding period (2021: operating cash outflows of $176,037).

3. Net tangible assets
	Reporting		Previous
	period		period
	Cents		Cents
Net tangible assets per ordinary security	1.42	1.67

Optiscan Imaging Limited

Appendix 4D

Half-year report

The net tangible assets per ordinary security has been calculated excluding the Right of use asset amount.

4.	Control gained over entities
only
	Not applicable.
5.	Loss of control over entities
	N	t applicable.
6.	Dividends
use

Current period

There were no dividends paid or declared during the current financial period.

Previous period

There were no dividends paid or declared during the previous financial period.

7. Dividend reinvestment plans personalNot applicable.

8. Details of associates and joint venture entities Not applicable.

9. Foreign entities

Details of origin of accounting standards used in compiling the report:

Not applicable.

10. Audit qualification or review

Details of audit/review dispute or qualification (if any):

ForThe financial statements were subject to a review by the auditors and the review report is attached as part of the Interim Report.

11. Attachments

Details of attachments (if any):

The Interim Report of Optiscan Imaging Limited for the half-year ended 31 December 2021 is attached.

Optiscan Imaging Limited Appendix 4D

Half-year report 12. Signed

personalForuse only	Date: 24 February 2022
Signed ___________________________
Robert Cooke
Non-executive Chairman

onlyOptiscan Imaging Limited

ABN 81 077 771 987

useInterim Report - 31 December 2021 personalFor

Optiscan Imaging Limited Corporate directory

31 December 2021

Directors

onlyCompany secretary Registered office

Principal place of business

useShare register

Auditor

personalStock exchange listing Website

For

Mr Robert Cooke (Non-executive Chairman)

Prof Camile Farah (Managing Director)

Ms Karen Borg (Non-executive Director)

Mr Ron Song (Non-executive Director)

Mr Justin Mouchacca

16 Miles Street

Mulgrave, Victoria, 3170

Phone No.: [phone]

Fax No.: [phone]

16 Miles Street

Mulgrave, Victoria, 3170

Phone No.: [phone]

Fax No.: [phone]

Computershare Investor Registry Services

Yarra Falls

452 Johnston Street

Abbotsford, Victoria, 3067

Phone No.: [phone]

Grant Thornton Audit Pty Ltd

Collins Square, Tower 5,

727 Collins Street, Melbourne VIC 3008

Australia

Optiscan Imaging Limited securities are listed on the Australian Securities Exchange (ASX code: OIL)

www.optiscan.com

1